An interventional study of acupressure and control (placebo) group in Pain and Pain Management, sponsored by Cukurova University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-20.
Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Pain by Cukurova University — 5 open to participants now, 8 under way, none of them phase 3. Pain · Cukurova University.
Among the 27 studies in Pain by Cukurova University, this one is the 26th largest by enrollment of the 26 interventional ones that give a count, is one of 7 that started in 2025, is one of 25 with no phase, and was the 27th registered.
10,060 studies on the registry are indexed under Pain; 1,651 are open to participants now.
Browse Pain studies →5 of the 27 studies in Pain by Cukurova University are open now, in 1 country. Recruiting first, the newest first:
Cukurova University · Sites in Turkey
Ages 18–65
Cukurova University · Sites in Turkey
Ages 18+
Cukurova University · Sites in Turkey
Ages 25–65 · Women only · Healthy volunteers
Cukurova University · Sites in Turkey
Ages 15–49 · Women only · Healthy volunteers
Cukurova University
Ages 18+
By country, each count listing its studies:
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.
This study: 6 Years to 12 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 7 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 41 is below the median of 66 across 8,497 interventional studies indexed under Pain.
Median enrollment 76 across the 26 interventional studies, 140 across the 1 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cukurova University is the lead sponsor of 259 studies on the registry; 50 are open to participants now.
1 of the studies in Pain by Cukurova University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07119983Cukurova UniversityEffect of Stress Ball Applied During Surgical Debridement/Dressing on Pain, Distress, and Physiological Parameters in Patients With Diabetic Foot Ulcers | 2027-01-01 |
Add it to your calendar (.ics) → With an account.
Among the 27 studies in Pain by Cukurova University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate pain in children during and after K-wire (Kirschner wire) removal and to investigate the effect of the intervention on pain. Children who are scheduled for K-wire removal will be included in the study. Participants will be assigned to an intervention group or a control group. Pain intensity will be assessed using the Visual Analog Scale (VAS), scored from 0 to 10. Pain assessments will be performed before and after the procedure. In addition to the child's pain rating, pain will also be assessed by the parent and the researcher. The pain scores will be compared to evaluate differences between the groups and changes in pain before and after the procedure.
This study is designed to evaluate pain associated with K-wire (Kirschner wire) removal in children and to compare pain outcomes between an intervention group and a control group. Children who meet the study eligibility criteria and are scheduled for K-wire removal will be included.
Participants will be assigned to an intervention group or a control group according to the study protocol. Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst possible pain). Pain will be assessed immediately before and after K-wire removal.
Pain assessments will be obtained independently from three perspectives: the child, the parent, and the researcher. The agreement among these three assessments will also be evaluated.
The primary purpose of the study is to determine whether the intervention is associated with a greater reduction in pain compared with the control condition. Pain scores before and after the procedure will be compared within and between the study groups.
The findings of this study may contribute to a better understanding of pain management during K-wire removal in children and may help inform clinical approaches for reducing procedural pain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Children aged 6-12 years. First-time K-wire removal following treatment for an elbow fracture. Able to communicate verbally and understand and speak Turkish. No chronic pain, psychiatric, developmental, or sensory disorders. No physical condition preventing acupressure application at the LI4 point. No opioid, narcotic analgesic, or sedative medication use within 8 hours before the procedure.
Written obtained from both the child and parent after being informed about the study.
Exclusion Criteria:
Requirement for analgesic or sedative medication during the procedure. K-wire removal not completed in a single session. Complications during the procedure, such as prolonged or traumatic K-wire removal.
Wound, infection, dressing, fracture, inflammation, or other local at the LI4 acupressure site.
Withdrawal of by the child or parent during the study
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive acupressure before K-wire removal.
Behavioral: acupressure
Participants will receive placebo acupressure before K-wire removal
Other: control (placebo) group
Participants in the placebo group will receive a touch procedure at the LI4 acupressure point without therapeutic acupressure stimulation. Pain will be assessed during and after K-wire removal. Anxiety and fear will be assessed before, during, and after the procedure.
Participants in the control group will receive a placebo acupressure procedure. Pressure will be applied to a location distant from the LI4 acupressure point, without stimulating the therapeutic LI4 point. Pain will be assessed during and after K-wire removal, while anxiety and fear will be assessed before, during, and after the procedure.
Primary Outcome Measure-Pain
Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst possible pain). Pain scores will be assessed during and after K-wire removal.
Time frame: Baseline and 2 hours
Anxiety assessed using the Child Anxiety Thermometeranxiety
Anxiety level will be assessed using the Child Anxiety Thermometer, a visual analog scale ranging from 0 (no anxiety) to 10 (very high anxiety). Anxiety scores will be assessed before, during, and after K-wire removal.
Time frame: Baseline and 2 hours
Plan to share: No
Started Jul 2025 (actual). Primary completion is estimated for Aug 2026, 13 months after the start.
Of 3,734 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 13 months is above that.
Counting every sponsor, half of 3,833 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.